Patent office eases rule for pharma companies – Livemint
0
“India’s patent office has conceded a key demand of the pharmaceutical industry, dropping a proposed clause that would have enforced a more stringent examination of patent applications. A clause in the draft rules, mandating the use of generic names of pharmaceutical substances to check whether discovery claims made in a drug patent application were already known or not, has been dropped in the final rules.”
From – Livemint